Hyperthermia has been utilized for cancer therapy, including metastatic cancer, for decades with isolated success. Previous research has indicated that the elevated temperature of 42°C induces cell death, apoptosis, or senescence of responsive cancers, providing a mechanism for tumor destruction and management. Veno-venous perfusion-induced systemic hyperthermia (V-V PISH) may be the key to improving advanced tumor responsiveness to previously failed chemotherapy and/or radiation as combination therapy. The most recent iteration of V-V PISH, Hyperthermic Extracorporeal Applied Tumor Therapy (HEATT®), provides homogeneous heating of all tissues with electrolyte and pH control and continues to prove safe and effective. The utilization of HEATT® in advanced, unresponsive cancers should be further explored as a part of integrative oncology care.
Zwischenberger, Joseph B.; Skaggs, Peyton; Breetz, Katherine; Winetz, Jan; and Vertrees, Roger
"Hyperthermic Extracorporeal Applied Tumor Therapy (HEATT®) in Advanced Unresponsive Cancer,"
Journal of Shock and Hemodynamics: Vol. 2(1)
Available at: https://digitalcommons.library.tmc.edu/josh/vol2/iss1/1